Skip to main content

Day: December 13, 2023

Retail Packaging Market Size Worth USD 7.65 Billion in 2032 | Emergen Research

Increasing consumer interest toward convenient and eco-friendly shopping solutions is a major factor driving Retail Packaging Market revenue growth Vancouver, Dec. 13, 2023 (GLOBE NEWSWIRE) — The global retail packaging market size is expected to reach USD 7.65 Billion in 2032 and register a steady revenue CAGR of 5.1% over the forecast period, according to latest analysis by Emergen Research. Technological advancements and introduction of the Internet of Packaging (IoP) are driving revenue growth of the market. The traditional packaging business is undergoing a technology transformation called the ‘Internet of Packaging,’ which will improve customer and brand interaction. Advanced technologies including QR codes, smart labels, Radio Frequency Identification (RFID), and Near Field Communication (NFC) chips are used in smart packaging....

Continue reading

Basalt Fiber Market Size Worth USD 586 Million in 2032 | Emergen Research

Rising demand for basalt fibers from the automotive industries to manufacture lightweight component is a key factor driving Basalt Fiber market revenue growth. Vancouver, Dec. 13, 2023 (GLOBE NEWSWIRE) — The global basalt fiber market size was USD 256 Million in 2022 and is expected to register a rapid revenue CAGR of 8.6% during the forecast period. The surge in demand for basalt fibers is attributed to their widespread application in the automotive and construction sectors. Automotive Original Equipment Manufacturers (OEMs) are increasingly turning to basalt fibers to create lightweight components without compromising strength, fostering a rapid shift towards Electric Vehicles (EVs), and enhancing safety in battery operation. The automotive and transport segment is poised to capture a substantial share of the global basalt fiber...

Continue reading

Aniline Market Size Worth USD 15.7 Million billion in 2032 | Emergen Research

Rising demand for aniline in the pharmaceutical sector and increasing need for Methylene Diphenyl Isocyanate (MDI) in sealants, adhesives, and coatings sectors are key factors driving Aniline Market revenue growth Vancouver, Dec. 13, 2023 (GLOBE NEWSWIRE) — The global aniline market is witnessing robust growth, reaching a size of USD 9.4 million in 2022 and projected to maintain a rapid revenue Compound Annual Growth Rate (CAGR) of 5.3% throughout the forecast period. Key drivers include the escalating demand for aniline in the pharmaceutical sector and the burgeoning need for Methylene Diphenyl Isocyanate (MDI) in sealants, adhesives, and coatings. Aniline, a crucial intermediary in medicinal product manufacturing, finds application in various sulfa pharmaceuticals, including penicillin derivatives. Continuous medicinal chemistry...

Continue reading

Extrusion Coatings Market Size Worth USD 9.50 billion in 2032 | Emergen Research

Rapid growth of the packaging industry and rising consumer demand from the Food & Beverage (F&B) industry are key factors driving Extrusion Coatings market revenue growth Vancouver, Dec. 13, 2023 (GLOBE NEWSWIRE) — The global extrusion coatings market, valued at USD 5.50 Billion in 2022, is anticipated to experience substantial growth with a robust CAGR of 5.6% during the forecast period. Key drivers include the rapid expansion of the packaging industry and heightened consumer demand, particularly in the Food & Beverage (F&B) sector. Extrusion coating, a process involving the application of thermoplastic polymeric materials onto various substrates, such as polyester films, aluminum foil, paperboard, or Biaxially Oriented Polypropylene (BOPP) films, is witnessing a surge in demand. Liquid packaging, a dominant...

Continue reading

Magnite to Participate in the Needham Annual Growth Conference

NEW YORK, Dec. 13, 2023 (GLOBE NEWSWIRE) — Magnite (Nasdaq: MGNI), the world’s largest independent sell-side advertising company, today announced that members of its executive team will present and host in-person investor meetings at the 26th Annual Needham Growth Conference in New York City on Thursday, January 18, 2024. The Magnite presentation will take place at 10:15 a.m. ET. A live webcast of the presentation will be available in the “Events & Presentations” section of Magnite’s investor relations website at: https://investor.magnite.com. The webcast replay will be available following the conclusion of the live presentation for 90 days. About Magnite We’re Magnite (NASDAQ: MGNI), the world’s largest independent sell-side advertising company. Publishers use our technology to monetize their content across all screens and...

Continue reading

Calavo Announces Earnings Release Date for Fourth Quarter and Fiscal Year End Results

SANTA PAULA, Calif., Dec. 13, 2023 (GLOBE NEWSWIRE) — Calavo Growers, Inc. (Nasdaq: CVGW), a global leader in the avocado and value-added fresh food industries, today announced that it will release financial results for the fiscal fourth quarter and 2023 fiscal year ended Oct. 31, 2023, after the market closes on Tuesday, January 16. Under SEC rules, the Company is required to determine its filer status for its Form 10-K as of the last business day of its most recently completed second fiscal quarter. Based on the aggregate worldwide market value of the Company’s common stock held by non-affiliates on April 28, 2023, the Company determined that it will be an “accelerated filer” for its fiscal 2023 Form 10-K and for each Form 10-Q during fiscal 2024. The Company’s Form 10-K for fiscal 2023 is therefore due on January 16, 2024, the...

Continue reading

85% of Bosses Recognize an Employee Burnout Crisis, Fear Challenges Retaining Talent in 2024

Fiverr revealed findings from a survey assessing the state of worker well-being in the US In addition to prioritizing well-being and flexibility in their work lives, 74% of workers surveyed said they plan to start or continue freelancing in 2024. 92%3 of business leaders said they believe working with freelancers has or will help full-time employees manage their workload NEW YORK, Dec. 13, 2023 (GLOBE NEWSWIRE) — Fiverr International Ltd., (NYSE: FVRR), the company that is changing how the world works together, revealed findings from a survey assessing the state of worker well-being in the US, and a lookahead to 2024 recruitment and retention trends. Fiverr conducted a nationwide survey of 1,000 US employees and freelancers and 501 US business leaders in partnership with Censuswide. In addition to prioritizing well-being...

Continue reading

Rezolute Completes Enrollment of its Phase 2 Study in Diabetic Macular Edema (“DME”)

Plans to report topline data mid-second quarter 2024 REDWOOD CITY, Calif., Dec. 13, 2023 (GLOBE NEWSWIRE) — Rezolute, Inc. (Nasdaq: RZLT), a clinical-stage biopharmaceutical company committed to developing novel, transformative therapies for serious metabolic and rare diseases, today announced the completion of enrollment in its RZ402 Phase 2 study in diabetic macular edema (“DME”). RZ402 is a selective and potent plasma kallikrein inhibitor (“PKI”) being developed as a potential oral therapy for the chronic treatment of DME. The study is a multi-center, randomized, double-masked, placebo-controlled, parallel-arm study to evaluate the safety, efficacy, and pharmacokinetics of RZ402 administered as a once daily oral monotherapy over a 12-week treatment period and four-week follow-up in participants with DME who are naïve to, or...

Continue reading

TFF Pharmaceuticals Appoints Thomas B. King to Board of Directors

FORT WORTH, Texas, Dec. 13, 2023 (GLOBE NEWSWIRE) — TFF Pharmaceuticals, Inc. (NASDAQ: TFFP), a clinical-stage biopharmaceutical company focused on developing and commercializing innovative drug products based on its patented Thin Film Freezing (TFF) technology platform, today announced the appointment of Thomas B. King to its Board of Directors. “I am pleased to welcome Thomas King to our Board of Directors,” said Harlan Weisman, M.D., Vice Chairman and Chief Executive Officer of TFF Pharmaceuticals. “Tom is an exceptionally accomplished executive who has held leadership positions at life sciences companies over the last three decades. In addition, his extensive board experience will provide us with valuable insights and perspectives as we seek to advance our two lead candidates, TFF VORI and TFF TAC, into later-stage clinical...

Continue reading

Centessa Pharmaceuticals to Present at the 42ⁿᵈ Annual J.P. Morgan Healthcare Conference

BOSTON and LONDON, Dec. 13, 2023 (GLOBE NEWSWIRE) — Centessa Pharmaceuticals plc (Nasdaq: CNTA), a clinical-stage pharmaceutical company that aims to discover and develop transformational medicines for patients, today announced its participation in the 42nd Annual J.P. Morgan Healthcare Conference in San Francisco, CA. Saurabh Saha MD PhD, Chief Executive Officer of Centessa, is scheduled to present at the conference on Wednesday, January 10, 2024, at 4:30 PM PST. The live audio webcast of this event, as well as an archived recording, will be available under the “Events and Publications” tab on the investor relations section of the Centessa Pharmaceuticals website at https://investors.centessa.com/events-presentations. About Centessa PharmaceuticalsCentessa Pharmaceuticals plc is a clinical-stage pharmaceutical company that aims...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Cookie Notice

We use cookies to improve your experience on our website

Information we collect about your use of Goldea Capital website

Goldea Capital website collects personal data about visitors to its website.

When someone visits our websites, we use a third party service, Google Analytics, to collect standard internet log information (such as IP address and type of browser they’re using) and details of visitor behavior patterns. We do this to allow us to keep track of the number of visitors to the various parts of the sites and understand how our website is used. We do not make any attempt to find out the identities or nature of those visiting our websites. We won’t share your information with any other organizations for marketing, market research or commercial purposes and we don’t pass on your details to other websites.

Use of cookies
Cookies are small text files that are placed on your computer or other device by websites that you visit. They are widely used to make websites work, or work more efficiently, as well as to provide information to the owners of the site.